Optum has signed on to the fight against obesity, backing the telemedicine programme provider and taking its overall funding to over $127m.

US-based weight loss software developer Calibrate secured $100m yesterday in a series B round that included healthcare services provider Optum, through corporate venturing unit Optum Ventures.

Founders Fund and Tiger Global Management co-led the round, with participation from Forerunner Ventures, Redesign Health and Threshold Ventures.

Founded in 2020, Calibrate offers a year-long metabolic reset telemedicine programme to help users shed weight, buoyed by US Food and Drug Administration-approved medication such as recently approved weight management injection Wegovy, along with behaviour…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn